The DEA desires to extend its COVID-19 prescription flexibilities; the Biden administration warns Americans to avoid medical credit cards; more US women are avoiding unwanted or ill-timed pregnancies, but a growing share of women over 35 say their pregnancies are coming later than desired.
As the end of the public health emergency for the COVID-19 pandemic rapidly approaches, the Drug Enforcement Administration (DEA) has submitted plans to prolong the flexibilities around telemedicine prescribing that were passed during the pandemic, reported The Hill. The agency had previously announced proposed rules in February to extend the COVID-19 flexibilities and allow providers to prescribe a 30-day supply of “Schedule III-V nonnarcotic controlled medications” and buprenorphine without an in-person evaluation or a referral from a separate practitioner who has conducted an in-person evaluation.
The Biden administration warned Americans about the financial risks of medical credit cards and other loans for medical bills on Thursday, cautioning in a new report that high interest rates can intensify patients’ debts and threaten their financial security, according to NPR. A new report from the Consumer Financial Protection Bureau estimated that US individuals paid $1 billion in deferred interest on medical credit cards and other medical financing from 2018 to 2020. The interest payments can expand medical bills by almost 25%, the agency found.
An analysis released last Thursday in the journal Demography by researchers at the Guttmacher Institute found that an increasing majority of US women from 2009 to 2015 said their pregnancies came at the right time, reported The New York Times. It revealed a decline in the share of pregnancies that women didn’t want or that happened too soon, a move driven by young women. The analysis also found that a significant and growing share of women—particularly those 35 years and older—said they were getting pregnant later than desired.
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More